Nestlé announces results of tender offer for Aimmune Therapeutics
VEVEY, SWITZERLAND: Société des Produits Nestlé S.A. (Nestlé) announced the results of the tender offer by its wholly-owned subsidiary, SPN MergerSub, Inc., to purchase all of the outstanding shares of common stock of Aimmune Therapeutics, Inc., other than any Shares held by Nestlé and its affiliates, for a price of USD 34.50 per Share. Equinity…